HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

glycyl-arginyl-glycyl-glutamyl-serine

Also Known As:

GRGES; Gly-Arg-Gly-Glu-Ser

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - glycyl-arginyl-glycyl-glutamyl-serine: 3

Experts

1.	Enjoji, Munechika: 1 article (12/2004)
2.	Fukushima, Marie: 1 article (12/2004)
3.	Kobayashi, Naoya: 1 article (12/2004)
4.	Kohjima, Motoyuki: 1 article (12/2004)
5.	Kotoh, Kazuhiro: 1 article (12/2004)
6.	Morizono, Shusuke: 1 article (12/2004)
7.	Nakamuta, Makoto: 1 article (12/2004)
8.	Nawata, Hajime: 1 article (12/2004)

Related Diseases

1.	Neoplasms (Cancer) 11/01/1987 - "Synthetic peptides GRGDS (50 micrograms/ml), but not GRGES, blocked tumor cell haptotaxis on fibronectin, but had minimal effect on thrombospondin or laminin haptotaxis. "
2.	Melanoma (Melanoma, Malignant) 02/25/1991 - "When RGDS peptide homologues were tested for their ability to inhibit spreading of melanoma cells on CS1- and CS5-IgG conjugates, GRGDS, GRGES, and REDV were found to be inhibitory, while GRDGS had no effect. "
3.	Fibrosis (Cirrhosis) 12/01/2004 - "The group treated with control peptide (GRGES) showed pathologically typical hepatic fibrosis, while the RGD-treated group showed minimal fibrotic changes. "

Related Drugs and Biologics

1.	Peptides (Polypeptides)
2.	glycyl-arginyl-glycyl-aspartyl-serine
3.	Thrombospondins
4.	Laminin (Merosin)
5.	Fibronectins (Fibronectin)
6.	arginyl-glycyl-aspartyl-serine